Biogen plans to invest another $10 million in BioMotiv LLC

Story excerpt provided by Crain’s Cleveland Business.

Written by Scott Suttell.

Pharmaceutical giant Biogen Inc. is expanding its relationship with BioMotiv LLC of Shaker Heights and plans to invest another $10 million in the therapeutic accelerator company associated with The Harrington Project for Discovery & Development at University Hospitals.

BioMotiv announced in a news release on Tuesday, Sept. 6, that its strategic partnership with Cambridge, Mass.-based Biogen now includes the ophthalmology therapeutic area, in addition to an existing neurology partnership.

Click here to read the complete article.

Originally published September 6, 2016.